Analysis Tools|
Allele Symbol Allele Name Allele ID |
Grhl3tm3.1Jane targeted mutation 3.1, Stephen M Jane MGI:5306651 |
||||||||||||||||||||||||||||
| Summary |
6 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• all die within 7 weeks of tamoxifen treatment
|
|
• regression of skin barrier function after tamoxifen treatment
• dye penetration is variegated matching the pattern of cre mediated gene deletion
|
|
• after tamoxifen treatment gross abnormalities and increased fragility are seen
|
|
• after tamoxifen treatment
|
|
• regression of skin barrier function after tamoxifen treatment
• dye penetration is variegated matching the pattern of cre mediated gene deletion
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• authors state that mice exhibit a phenotype identical to Grhl3tm1Jane/Grhl3tm3.1Jane Tg(KRT14-cre)8Brn mice
|
|
• authors state that mice exhibit a phenotype identical to Grhl3tm1Jane/Grhl3tm3.1Jane Tg(KRT14-cre)8Brn mice
|
|
• authors state that mice exhibit a phenotype identical to Grhl3tm1Jane/Grhl3tm3.1Jane Tg(KRT14-cre)8Brn mice
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• from E18.5 through 8 weeks, mice exhibit normal skin barrier formation
(J:178952)
• no overt skin barrier defect or abnormality of the cornified envelope of the stratum corneum from birth to 6 weeks of age
(J:233531)
|
|
• in aged mice
|
|
• spontaneously in aged mice affecting the snout and neck
• in 4 weeks after DMBA/TPA treatment
|
|
• spontaneously in aged mice affecting the snout and neck
• in 4 weeks after DMBA/TPA treatment
|
|
• 4 weeks after DMBA/TPA treatment, mice develop skin papillomas many which progress to squamous cell carcinomas unlike control mice
|
|
• spontaneously in aged mice affecting the snout and neck
• in 4 weeks after DMBA/TPA treatment
|
|
• spontaneously in aged mice affecting the snout and neck
• in 4 weeks after DMBA/TPA treatment
|
|
• 4 weeks after DMBA/TPA treatment, mice develop skin papillomas many which progress to squamous cell carcinomas unlike control mice
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• present in expected numbers at E18.5 but all died by P3 with most lost during the first 48 hours after birth
|
|
• at P2 excessive fluid loss and regression of skin barrier function leads to dehydration and death
|
|
• loss of cornified envelope integrity by P2
|
|
• at P2 excessive fluid loss and regression of skin barrier function leads to dehydration and death
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• present in expected numbers at E18.5 and 6 weeks of age
|
| N |
• no evidence of skin barrier dysfunction was seen
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/09/2024 MGI 6.24 |
|
|
|
||
